Free shipping on all orders over $ 500

Netupitant

Cat. No. M3882

All AbMole products are for research use only, cannot be used for human consumption.

Netupitant Structure
Synonym:

CHEBI441603, CID6451149, D05152

Size Price Availability Quantity
5mg USD 60  USD60 In stock
10mg USD 85  USD85 In stock
50mg USD 240  USD240 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Netupitant competitively binds to and blocks the activity of the human substance P/NK1 receptors in the central nervous system (CNS), thereby inhibiting NK1-receptor binding of the endogenous tachykinin neuropeptide substance P (SP), which may result in the prevention of chemotherapy-induced nausea and vomiting (CINV). Recent mechanistic studies using NG108-15 cells have shown that palonosetron and netupitant, an NK1 receptor antagonist currently in phase 3 clinical trials, exhibited synergistic effects when inhibiting the substance P response.The present studies showed that both netupitant and palonosetron-induced NK1 receptor internalization in NG108-15 cells and that when used together receptor internalization was additive.Netupitant was well tolerated with most treatment emergent adverse events (AEs) being mild.Palonosetron and netupitant, either alone or in combination, were effective in reducing the induced elevated pPKA levels during the delayed phase.

Chemical Information
Molecular Weight 578.59
Formula C30H32F6N4O
CAS Number 290297-26-6
Solubility (25°C) DMSO 6 mg/mL heat to 50°C and ultrasonic
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Darmani NA, et al. Pharmacol Biochem Behav. Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1/2, PKA and PKC activation.

[2] Thomas AG, et al. Exp Brain Res. Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells.

[3] Haab F, et al. Neurourol Urodyn. Efficacy and safety of repeated dosing of netupitant, a neurokinin-1 receptor antagonist, in treating overactive bladder.

Related Neurokinin Receptor Products
GR203040 

GR203040 is an orally active NK1 receptor antagonist with a pKi of 10.3.

Ezlopitant

Ezlopitant (CJ-11,974) is a selective, non-peptidic neurokinin-1 (NK-1)-receptor antagonist.

CP 122721 hydrochloride 

CP 122721 hydrochloride is a potent, non-peptide and selective nonpeptide neurokinin NK1 antagonist, with a pIC50 of 9.8 for human NK1 receptor expressed in IM-9 cells.

Spantide II

Spantide II, an undecapeptide substance P (SP) analog, is a potent neurokinin-1 receptor (NK-1R) antagonist.

Substance P (7-11)

Substance P (7-11) is a C-terminal fragment of Substance P which can cause an increase in the intracellular calcium concentration.

  Catalog
Abmole Inhibitor Catalog




Keywords: Netupitant, CHEBI441603, CID6451149, D05152 supplier, Neurokinin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.